Robert Flisiak
Experienced in Thrombocytopenia

Robert Flisiak

14 Żurawia St, 
Bialystok, PD, PL 
Experienced in Thrombocytopenia
14 Żurawia St, 
Bialystok, PD, PL 
OverviewLocationsClinical Research

Overview

Robert Flisiak practices in Bialystok, Poland. Mr. Flisiak is rated as an Experienced expert by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Hepatitis, Hepatitis C, Hepatitis B, Liver Transplant, and Kidney Transplant.

His clinical research consists of co-authoring 313 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Thrombocytopenia.

Gender
Male

Locations

14 Żurawia St, Bialystok, PD 15540, Poland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
Real World Evidence (RWE) of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Poland (HCV RWE PMOS)
Real World Evidence (RWE) of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Poland (HCV RWE PMOS)
Enrollment Status: Completed
Publish Date: October 17, 2018
View 1 Less Clinical Trial

312 Total Publications

Joint association of body mass index and lipoprotein(a) with atrial fibrillation prevalence: an observational and mendelian randomization study.
Joint association of body mass index and lipoprotein(a) with atrial fibrillation prevalence: an observational and mendelian randomization study.
Journal: Polish archives of internal medicine
Published: October 07, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Flisiak's expertise for a condition
ConditionClose
View All 27 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile